Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (CRBP)

Q: What does CUSIP 21833P301 represent in this 13F holders report?

CUSIP 21833P301 is the security identifier for CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (the "Shares") in Q2 2026?

107 institutional investors reported CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (the "Shares") for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 21833P301

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share (the "Shares")
Total 13F shares: 13,766,527
Total 13F value: $129,111,329
Share change: +870,480
Put/Call ratio: 3.4%
SEC-reported price per share: $9.38
Number of holders: 107
Value change: +$8,137,283
Number of buys: 51
Number of sells: 49
Shares outstanding: 18,532,780

Security key

21833P301

Report period

Q2 2026

Institutions

107

Top holders

CRBP full security history Ownership snapshot Full 13F holder table Corbus Pharmaceuticals Holdings, Inc. SEC filings Corbus Pharmaceuticals Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Cormorant Asset Managemen...

Disclosed value leader

Cormorant Asset Managemen...

Comparable rows

15/15

Latest evidence

30 Jun 2026

3/4/5 13D/G 13F Lead comparable stake: 13% 13D/G row: Cormorant Asset Management, LP Showing 1-6 of 15 holder rows.

Quick read

Cormorant Asset Management, LP leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Cormorant Asset Management, LP's linked filing trail.

Comparable ownership Top 5

Cormorant Asset Management, LP 13%

Aberdeen Group plc 7.5%

ORBIMED ADVISORS LLC 5.9%

BlackRock, Inc. 5.9%

VANGUARD GROUP INC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Cormorant Asset Management, LP	3/4/5 13D/G 13F 10%+ Owner · Company 3/4/5 13D/G 13F	13% from 13D/G	$26,863,987 2,344,971 shares	-$344,012	11 Dec 2025
Aberdeen Group plc	13F 13D/G Company 13F 13D/G	7.5% from 13D/G	$12,411,233 1,321,750 shares	—	31 Mar 2026
ORBIMED ADVISORS LLC	13F 13D/G Company · OrbiMed Capital LLC 13F 13D/G	5.9% from 13D/G	$16,313,125 1,737,287 shares	—	31 Mar 2026
BlackRock, Inc.	13D/G 13F Company 13D/G 13F	5.9%	$10,256,411 1,093,434 shares	+$6,950,814	30 Jun 2026
VANGUARD GROUP INC	13D/G The Vanguard Group 13D/G	4.9%	$4,136,516 599,495 shares	$0	30 Jun 2025
VANGUARD CAPITAL MANAGEMENT LLC	13F Company 13F	4%	$6,893,255 734,106 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

107

13,766,527

Rows available

107

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

107

Q2 2026 holders

107

Holder diff

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %